KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LPCN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Lipocine Inc. stock price ended at $4.55 on Thursday, after gaining 2.48%.
(Updated on Apr 25, 2024)

Sell candidate since Apr 24, 2024 Gain 2.48% PDF

The Lipocine Inc. stock price gained 2.48% on the last trading day (Thursday, 25th Apr 2024), rising from $4.44 to $4.55. During the last trading day the stock fluctuated 4.41% from a day low at $4.41 to a day high of $4.60. The price has fallen in 7 of the last 10 days and is down by -29.02% for this period. Volume fell on the last day by -58 thousand shares and in total, 8 thousand shares were bought and sold for approximately $36.05 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.47 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 34.27% during the next 3 months and, with a 90% probability hold a price between $6.00 and $9.16 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LPCN Signals & Forecast

There are few to no technical positive signals at the moment. The Lipocine Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $4.98 and $4.83. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 10, 2024, and so far it has fallen -30.11%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Lipocine Inc. stock

Lipocine Inc. finds support from accumulated volume at $4.44 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.195 between high and low, or 4.41%. For the last week the stock has had daily average volatility of 7.85%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LPCN) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Lipocine Inc. to open at $4.52, and during the day (based on 14 day Average True Range), to move between $4.05 and $5.05, which gives a possible trading interval of +/-$0.500 (+/-11.00%) up or down from last closing price. If Lipocine Inc. takes out the full calculated possible swing range there will be an estimated 22.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.44 (2.42%) than the resistance at $4.69 (3.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Lipocine Inc. stock A Buy?

The Lipocine Inc. stock holds several negative signals and despite the positive trend, we believe Lipocine Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -5.136 Strong Sell Candidate Unchanged

Predicted Opening Price for Lipocine Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$4.52 ( 0.625%) $4.55

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LPCN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.72 3.65 %
R2 4.64 2.02 %
R1 4.60 1.01 %
Current price: 4.55
Support S1 4.45 -2.26 %
S2 4.40 -3.27 %
S3 4.33 -4.90 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.80 5.49 %
R2 4.79 5.27 %
R1 4.69 3.08 %
Current price 4.55
Support S1 4.44 -2.42%
S2 3.96 -12.97%
S3 3.94 -13.41%

FAQ

What is the symbol for Lipocine Inc. Stock and on which exchange is it traded?
The symbol for Lipocine Inc. is LPCN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lipocine Inc. Stock?
The Lipocine Inc. stock holds several negative signals and despite the positive trend, we believe Lipocine Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Lipocine Inc. Stock?
Lipocine Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lipocine Inc. Stock.

What's the current price of Lipocine Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Lipocine Inc. (LPCN) share was $4.55.

What is the 52-week high and low for Lipocine Inc. Stock?
The 52-week high for Lipocine Inc. Stock is $7.14 and the 52-week low is $0.230.

What is the market capitalization of Lipocine Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Lipocine Inc. is 24.187M.

When is the next earnings date for Lipocine Inc.?
The upcoming earnings date for Lipocine Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Lipocine Inc.

Lipocine. Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioident... LPCN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT